The general mood among these heavyweight investors is divided, with 63% leaning bullish and 36% bearish. Among these notable ...

Investing.com – U.S. stocks were lower after the close on Monday, as losses in the Consumer Services, Technology and Basic ...

The company has a development and sales collaboration with Merck & Co., Inc. and AstraZeneca UK Limited to develop anti-cancer drugs. Daiichi Sankyo Company, Limited was founded in 1899 and is ...

* EPS estimates are Normalized unless otherwise noted.

Recently reported positive preliminary data from Phase 1 dose escalation trial of micvotabart pelidotin ("MICVO," formerly PYX-201), including a confirmed 50% objective response rate by RECIST 1.1 ...